Spectroscopic Study of Methylene Blue Interaction with Coenzymes and its Effect on Tumor Metabolism. (2025)

Peer-Reviewed Study · Pominova DV; Ryabova AV; Skobeltsin AS; Markova IV; Romanishkin ID · February 28, 2025

Pominova DV et al., 2025-02-28: Russian spectroscopic and mouse study of methylene blue in Ehrlich carcinoma: intravenous methylene blue produced no tumour-growth reduction, while methylene blue given in drinking water slowed tumour growth and shifted metabolism from glycolysis toward oxidative phosphorylation.

In the experiments in vivo, no noticeable tumor growth rate reduction was observed in the groups with intravenous MB introduction in comparison with the control. In the group receiving MB with drinking water, a decrease of the tumor growth rate, reduction of oxygenation level, and a1/a2 metabolic index were observed, which confirms the shift from glycolysis to oxidative phosphorylation.

Pominova DV et al., 2025-02-28: Russian spectroscopic and mouse study of methylene blue in Ehrlich carcinoma: intravenous methylene blue produced no tumour-growth reduction, while methylene blue given in drinking water slowed tumour growth and shifted metabolism from glycolysis toward oxidative phosphorylation. C1 Pominova 2025. Study type: in vitro spectrophotometry plus in vivo mouse tumour model (Ehrlich carcinoma); N not stated in the abstract. Country: Russia (federal research centre, Nizhny Novgorod – 'Sovremennye Tekhnologii v Meditsine' is a Russian journal). Dose/route/schedule/duration: not stated in the abstract text captured; routes compared were intravenous and oral (drinking water). Funder: 'Research Support, Non-U.S. Gov't'; specific funder not in the record. Conflicts: 'The authors have no conflicts of interest to declare.' Comparator: control mice without methylene blue. PARTLY because the metabolic shift was seen with oral dosing but not with intravenous dosing, and the authors state therapy time and concentration need optimisation. Study type: animal.